🇺🇸 FDA
Patent

US 7972854

Methods and compositions for targeted cleavage and recombination

granted A61PA61P31/12

Quick answer

US patent 7972854 (Methods and compositions for targeted cleavage and recombination) held by Sangamo Biosciences, Inc. expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P31/12